| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |